Skip to content

Amniotic Membrane in Extravsation

Evaluation Efficacy of Amniotic Membrane in Treatment of Extravasation in Infants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191024045229N2
Enrollment
4
Registered
2020-02-02
Start date
2020-01-20
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extravasation Leak. Extravasation of other vesicant agent, initial encounter

Interventions

Intervention group: Intervention group: Amniotic Membrane dressing (Sinacell Co.) as Allograft every 7 days, dressing size selection based on wound dimensions, until epithelization.

Sponsors

Research deputy of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 3 Years

Inclusion criteria

Inclusion criteria: Infant with diagnosis of wound due to drug leak

Exclusion criteria

Exclusion criteria: Wound with stage 1 or 2 Congenital skin disorders

Design outcomes

Primary

MeasureTime frame
Time to epithelization. Timepoint: Before intervention and weekly until epithelization. Method of measurement: Logging the time (day).

Secondary

MeasureTime frame
Scar Forming after Wound Treatment. Timepoint: After Wound Healing. Method of measurement: 'Vancouver Scare Scale' questionnaire.;Hospitalization Period. Timepoint: During the Study until epithelization. Method of measurement: Documents Assessment.;Sepsis. Timepoint: Before the initiation of intervention and then weekly. Method of measurement: Clinical assessment and blood sampling.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Kadivar

Tehran University of Medical Sciences

Kadivarm@tums.ac.ir+98 21 6147 9000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026